The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-02-01

Study Completion Date

2025-01-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to explore the relationship between related blood indicators and diabetic peripheral neuropathy(DPN).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

NCT06041399

Diabetic Peripheral Neuropathy

UNKNOWN PHASE4

Diagnostic Accuracy of Quantitative Neuropad Test for Diabetic Peripheral Neuropathy

NCT05347420

Diabetic Peripheral Neuropathy

UNKNOWN

Pain Diabetic Peripheral Neuropathy（DPN) in China

NCT04456465

Diabetic Neuropathies

COMPLETED

Muscle and Bone in Patients with Diabetes Mellitus and Neuropathy

NCT06519942

Diabetes Mellitus, Type 2 Diabetic Peripheral Neuropathy Sarcopenia

RECRUITING

Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnt

NCT03520608

Painful Diabetic Peripheral Neuropathy

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multicenter study(approximately four) with over 1000 subjects.Clinical data were collected by consulting the patient's electronic history. The data included demographic information, blood biochemical markers and electromyography. All participants provided their written informed consent to participate in this study.The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University(KY-2022-R009).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Peripheral Neuropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DPN group

Patients with type 2 diabetic peripheral neuropathy were categorized into the DPN group

No interventions assigned to this group

Diabetic group

patients with type 2 diabetes mellitus but not with DPN were distributed into the Diabetic group.

No interventions assigned to this group

control group

The other individuals without type 2 diabetes mellitus were selected as the control group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who had undergone nerve conduction examination by electromyography.

Exclusion Criteria

* pregnancy and lactation; chronic liver disease, kidney disease, arrhythmias, malignant diseases, severe respiratory diseases, heart failure, and acute infections;
* patients with alcohol abuse; history of Autoimmune liver disease, liver disease or abnormal liver function at baseline;
* parathyroid diseases (including hyperthyroidism and hypothyroidism);
* pancreatitis, pancreatectomy or any transplant;
* patients with malignancy and any serious concomitant disease limit the existence of life expectancy

Eligible Sex

ALL

Accepts Healthy Volunteers

No